Monday, October 14, 2019
Home Innovation That Matters

Innovation That Matters

Halozyme Utilizing Unique Tumor Microenvironment Pathway to Fight Pancreatic Cancer

In WuXi AppTec’s latest series on novel drug development for pancreatic cancer, most of the companies featured have concentrated on ways to directly stimulate the patient’s own immune system to fight this stubborn disease. Halozyme, a clinical stage oncology company based in...

Finch Therapeutics Taps into the Human Microbiome to Find Disease Causes and Cures

Finch Therapeutics is developing microbial therapies designed to alter the microbiome for treatment of patients suffering from diseases as varied as bacterial infections and autism. In 2019, the company received a Breakthrough Therapy designation from the US Food and Drug Administration (FDA)...

Blaze Bioscience Shines a Light on Tumor Cells to Guide Pediatric Brain Cancer Surgeons

Blaze Bioscience is literally lighting the way for cancer surgeons to remove children’s brain tumors without harming their healthy neural tissues. The company is developing drugs that use optimized CDPs, also called cystine-dense miniproteins, derived from natural organisms such...

Oncternal Therapeutics Pursuing Novel Treatment for Ewing Sarcoma in Challenging Field of Pediatric Cancer

The WuXi AppTec Communications team is excited to kick-off a new series on pediatric cancer that highlights companies seeking novel therapies for children, long a challenging space. Drug development advances in the last decade have produced new treatments for many diseases. However, since most of those...

Redefining Therapeutics Through Control of Gene Expression, a Conversation with Nancy Simonian, M.D., President and CEO, Syros Pharmaceuticals

By Rich Soll, Senior Advisor, Strategic Initiatives, WuXi AppTec (@richsollwx) and the WuXi AppTec Content Team Drug development is a very risky business. For more than 20 years, Nancy Simonian, an accomplished veteran drug developer (having served as...

SUBSCRIBE TO OUR NEWSLETTER

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast...

SHANGHAI, CHINA; CAMBRIDGE, MASSACHUSETTS, USA; SANKT AUGUSTIN, GERMANY Oct 10, 2019 - WuXi AppTec Research Service Division and BioSolveIT today launched a new virtual...